MCM
GBIO

Manchester Capital Management’s Generation Bio GBIO Stock Holding History

Manchester Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300
Closed -$11.4K – 1032
2023
Q3 		$11.4K Hold
300
– – ﹤0.01% 573
2023
Q2 		$16.5K Hold
300
– – ﹤0.01% 516
2023
Q1 		$12.9K Hold
300
– – ﹤0.01% 522
2022
Q4 		$11.8K Hold
300
– – ﹤0.01% 449
2022
Q3 		$16K Hold
300
– – ﹤0.01% 421
2022
Q2 		$20K Buy
300
+200
+200% +$13.1K ﹤0.01% 413
2022
Q1 		$7K Hold
100
– – ﹤0.01% 595
2021
Q4 		$7K Hold
100
– – ﹤0.01% 608
2021
Q3 		$25K Buy
+100
New +$23.9K ﹤0.01% 486

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Manchester Capital Management's GBIO Position: Q4 2023 in Review

Manchester Capital Management sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 300 shares — an estimated $11.4K sold.

Manchester Capital Management first reported a position in GBIO in Q3 2021 and held it in 9 quarters. The position peaked at $25K in Q3 2021. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • Manchester Capital Management reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • Manchester Capital Management sold 300 Generation Bio shares in Q4 2023, an estimated $11.4K.
  • Manchester Capital Management first reported a position in Generation Bio in Q3 2021 and held it in 9 quarters.
  • Manchester Capital Management's Generation Bio position peaked at $25K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on Manchester Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.